Immuneering Corporation (IMRX)
NASDAQ: IMRX · Real-Time Price · USD
4.060
+0.060 (1.50%)
Jul 25, 2025, 4:00 PM - Market closed
Immuneering Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2020 |
---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2020 |
Cash & Equivalents | 35.87 | 36.14 | 59.41 | 72.64 | 74.89 | 37.09 | Upgrade |
Short-Term Investments | - | - | 26.26 | 32.89 | 74.31 | - | Upgrade |
Cash & Short-Term Investments | 35.87 | 36.14 | 85.67 | 105.52 | 149.2 | 37.09 | Upgrade |
Cash Growth | -49.68% | -57.81% | -18.82% | -29.27% | 302.26% | 169.12% | Upgrade |
Receivables | - | - | - | 0.01 | 0.25 | 0.5 | Upgrade |
Prepaid Expenses | 2.34 | 3.44 | 3.42 | 3.21 | 2.89 | 0.14 | Upgrade |
Total Current Assets | 38.21 | 39.59 | 89.08 | 108.75 | 152.33 | 37.73 | Upgrade |
Property, Plant & Equipment | 4.63 | 4.79 | 5.4 | 5.78 | 6.13 | 0.68 | Upgrade |
Long-Term Investments | - | - | - | - | 1 | - | Upgrade |
Goodwill | 6.69 | 6.69 | 6.69 | 6.69 | 6.7 | - | Upgrade |
Other Intangible Assets | 0.34 | 0.35 | 0.38 | 0.41 | 0.44 | - | Upgrade |
Other Long-Term Assets | 0.81 | 1.3 | 1.03 | 0.74 | 0.1 | 0.01 | Upgrade |
Total Assets | 50.68 | 52.71 | 102.58 | 122.37 | 166.7 | 38.42 | Upgrade |
Accounts Payable | 1.31 | 1.96 | 2.11 | 3.15 | 1.39 | 1.48 | Upgrade |
Accrued Expenses | 3.39 | 4.97 | 5.17 | 4.5 | 3.97 | 0.7 | Upgrade |
Current Portion of Leases | 0.35 | 0.34 | 0.3 | 0.38 | 0.27 | 0.08 | Upgrade |
Other Current Liabilities | 0.06 | 0.23 | 0.26 | 0.02 | - | - | Upgrade |
Total Current Liabilities | 5.11 | 7.5 | 7.85 | 8.05 | 5.63 | 2.26 | Upgrade |
Long-Term Leases | 3.73 | 3.82 | 4.16 | 4.46 | 5.09 | 0.54 | Upgrade |
Total Liabilities | 8.84 | 11.33 | 12.01 | 12.52 | 10.72 | 2.8 | Upgrade |
Common Stock | 0.04 | 0.03 | 0.03 | 0.03 | 0.03 | 0 | Upgrade |
Additional Paid-In Capital | 281.15 | 265.65 | 253.81 | 219.64 | 215.28 | 3.25 | Upgrade |
Retained Earnings | -239.34 | -224.3 | -163.26 | -109.79 | -59.27 | -25.74 | Upgrade |
Comprehensive Income & Other | - | - | -0 | -0.03 | -0.05 | - | Upgrade |
Total Common Equity | 41.84 | 41.39 | 90.58 | 109.85 | 155.98 | -22.48 | Upgrade |
Shareholders' Equity | 41.84 | 41.39 | 90.58 | 109.85 | 155.98 | 35.62 | Upgrade |
Total Liabilities & Equity | 50.68 | 52.71 | 102.58 | 122.37 | 166.7 | 38.42 | Upgrade |
Total Debt | 4.08 | 4.16 | 4.46 | 4.84 | 5.36 | 0.62 | Upgrade |
Net Cash (Debt) | 31.78 | 31.98 | 81.2 | 100.68 | 144.83 | 36.47 | Upgrade |
Net Cash Growth | -52.49% | -60.61% | -19.35% | -30.48% | 297.13% | 255.02% | Upgrade |
Net Cash Per Share | 1.01 | 1.07 | 2.86 | 3.82 | 10.64 | 7.37 | Upgrade |
Filing Date Shares Outstanding | 35.99 | 35.89 | 29.28 | 26.44 | 26.38 | 4.95 | Upgrade |
Total Common Shares Outstanding | 35.99 | 31.05 | 29.27 | 26.42 | 26.32 | 4.95 | Upgrade |
Working Capital | 33.1 | 32.08 | 81.24 | 100.69 | 146.7 | 35.48 | Upgrade |
Book Value Per Share | 1.16 | 1.33 | 3.09 | 4.16 | 5.93 | -4.54 | Upgrade |
Tangible Book Value | 34.81 | 34.35 | 83.51 | 102.75 | 148.84 | -22.48 | Upgrade |
Tangible Book Value Per Share | 0.97 | 1.11 | 2.85 | 3.89 | 5.65 | -4.54 | Upgrade |
Machinery | 1.91 | 1.91 | 1.83 | 1.5 | 0.83 | 0.19 | Upgrade |
Leasehold Improvements | 0.3 | 0.3 | 0.3 | 0.29 | 0.15 | - | Upgrade |
Updated Mar 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.